
<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link rel="stylesheet" href="../style.css">
    <title>Document</title>
</head>
<body>

<span class="table_title">False Negatives</span>

<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th>generated</th>
      <th>gold</th>
      <th>text</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th>2</th>
      <td></td>
      <td>30-minute</td>
      <td>Potential TDI of P450 enzyme activity by CAW-R61J was determined using the shift in IC50 values between 30-minute preincubations in the presence and absence of NADPH.</td>
    </tr>
    <tr>
      <th>29</th>
      <td></td>
      <td>12 weeks</td>
      <td>Resting lactate level was measured at baseline and after 12 weeks, and results are presented in Figure 2.</td>
    </tr>
    <tr>
      <th>27</th>
      <td></td>
      <td>for 7 days</td>
      <td>Group I and II were orally administered with normal saline for 7 days and Group II was orally administered DAS (25 mg/kg) on the 7th day.</td>
    </tr>
    <tr>
      <th>34</th>
      <td></td>
      <td>30 days</td>
      <td>Female volunteers were excluded if they were pregnant (positive test for serum human chorionic gonadotropin at screening or check-in), breastfeeding, or planning to conceive a child within 30 days of treatment cessation.</td>
    </tr>
    <tr>
      <th>32</th>
      <td></td>
      <td>for 3 days</td>
      <td>However, a daily Gouqizi dose of 6 g (dosing recommended by Chinese Pharmacopoeia) for 3 days did not enhance the effects of warfarin in three patients with prosthetic heart values who were concomitantly taking warfarin.</td>
    </tr>
    <tr>
      <th>21</th>
      <td></td>
      <td>for 8 days</td>
      <td>The following treatments were administered for 8 days each: placebo twice daily (treatment A), EGb 761® 120 mg twice daily (treatment B), and EGb 761® 240 mg in the morning and placebo in the evening (treatment C).</td>
    </tr>
    <tr>
      <th>11</th>
      <td></td>
      <td>women<br>within the last year<br>within 4 wk<br>more than 10 h<br>within 6 mo<br>within 1 mo<br>within 3 mo<br>after 1 yr</td>
      <td>Meanwhile, the exclusion criteria were: 1) women who became menopausal from surgery or chemotherapy; 2) women who underwent hysterectomy; 3) women with a history of endometrial hyperplasia or endometrial, breast, or sex hormone–related cancers; 4) women with uncontrolled hypertension (160/100 mmHg or higher); 5) women with uncontrolled diabetes mellitus (fasting blood sugar 180 mg/dL or higher, or cases of starting or changing medication due to diabetes within 3 mo); 6) uncontrolled thyroid patients; 7) women who have had severe migraines within the last year or who have been diagnosed with thromboembolism, cerebrovascular disease, or serious cardiovascular disease; 8) women with atypical uterine bleeding after 1 yr of menopause; 9) women who have taken sleep inducers, antidepressants, selective estrogen receptor modulators, antihyperlipidemic drugs, antithrombotic drugs (Aspirin, Warfarin, and Clopidogrel), bisphosphonates, or calcitonin within 4 wk; 10) women who have taken plant hormones (isoflavone, flaxseed, pomegranate, horseradish, white sorghum, red shamrock, and red ginseng products) in the form of supplements or medicines within 4 wk; 11) women who have continuously taken functional foods and herbal medicines that could affect bone health, blood lipid lipids (triglyceride and cholesterol), and blood circulation within 4 wk; 12) women who were administered female hormone formulations within 6 mo; 13) women with alanine aminotransferase (ALT) or aspartate aminotransferase (AST) levels exceeding 3 times the laboratory's normal upper limit; 14) women with creatinine levels exceeding 2 times the laboratory's normal upper limit; 15) women with a history of drug or alcohol abuse; 16) women who have performed intensive exercises (more than 10 h) within 3 mo; 17) women with hypersensitivity to the test drug or its ingredients; 18) women with clinically significant abnormalities based on mammographies or Pap smears (Category 0 or higher than 3 of Breast Imaging Reporting and Data System (BI-RADS)) is confirmed (in the case of BI-RADS Category 0, subject registration is possible after confirming additional test results; in the case of Pap smear, atypical squamous cell of undetermined significance can be registered); 19) women who have participated in other clinical trials within 1 mo of the start of the current study or who are planning to participate in another clinical trial during the study period; and, 20) in cases where the researchers decided that the subject is unsuitable to participate in this study.</td>
    </tr>
    <tr>
      <th>19</th>
      <td></td>
      <td>1-week</td>
      <td>Plasma concentration-time profiles of the ginsenosides (A) Rb1, (B) Rb2, (C) Rc, (D) Rd, (E) PPD, and (F) PPT in the rat plasma after 1-week repeated administration of red ginseng extract (RGE).</td>
    </tr>
    <tr>
      <th>10</th>
      <td></td>
      <td>hours to months</td>
      <td>Although DIP can occur from hours to months after the beginning of treatment, Another typical feature of DIP is its reversibility after drug discontinuation.</td>
    </tr>
    <tr>
      <th>9</th>
      <td></td>
      <td>7 days</td>
      <td>Subjects also received rifampin (600 mg) and clarithromycin (1000 mg) for 7 days as positive controls for CYP3A induction and inhibition, respectively.</td>
    </tr>
    <tr>
      <th>20</th>
      <td></td>
      <td>±1 day</td>
      <td>For each visit, a deviation of ±1 day was permitted.</td>
    </tr>
    <tr>
      <th>6</th>
      <td></td>
      <td>14 subsequent days</td>
      <td>Daily before going to bed, participants took two tablets, with 500 mg valerian extract each (extraction solvent ethanol 70%, valerenic acid content 5.51 mg/tablet), for 14 subsequent days.</td>
    </tr>
    <tr>
      <th>1</th>
      <td></td>
      <td>for 1 or 2 weeks</td>
      <td>After RGE was orally administered to rats at single or multiple doses for 1 or 2 weeks, the plasma concentrations of ginsenosides were also monitored.</td>
    </tr>
    <tr>
      <th>5</th>
      <td></td>
      <td>for 5 days</td>
      <td>(2007) also investigated the effect of pretreatment with cranberry juice for 5 days on warfarin pharmacokinetics and found no clinically significant change in the AUC of S-warfarin.</td>
    </tr>
    <tr>
      <th>3</th>
      <td></td>
      <td>for 72 h</td>
      <td>The material was allowed to extract for 72 h at room temperature during which supernatant was decanted every 24 h and the solid residue reconstituted in the same volume of purified water for the extraction process to be repeated.</td>
    </tr>
    <tr>
      <th>22</th>
      <td></td>
      <td>1 week</td>
      <td>A maximum exposure was realized with a 240-mg EGb 761® daily dose, and exposure duration was sufficient to eventually induce CYPs, as steady state for EGb 761® components was reached, and 1 week is typically sufficient to achieve full induction [35].</td>
    </tr>
    <tr>
      <th>30</th>
      <td></td>
      <td>for two weeks</td>
      <td>daily for two weeks at morning and a single captopril dose (4.5 mg/200 g BW; p.o.)</td>
    </tr>
    <tr>
      <th>7</th>
      <td></td>
      <td>12 weeks<br>15 days</td>
      <td>Haloperidol (38 mg/kg bw) was applied intramuscularly once every 4 weeks over 12 weeks beginning after 15 days of treatment with valerian [51].</td>
    </tr>
    <tr>
      <th>0</th>
      <td></td>
      <td>the past two decades</td>
      <td>During the past two decades, the world has witnessed an increased rate of conventional medicines integrated with CAM for treatment.</td>
    </tr>
    <tr>
      <th>4</th>
      <td></td>
      <td>week</td>
      <td>Therefore, two simulation scenarios were used to evaluate the magnitude of any interaction, (AAP 1000 mg once daily + GGT 7680 mg once daily) and (AAP 1000 mg × 4 times daily + GGT 7680 mg once daily) in a week.</td>
    </tr>
    <tr>
      <th>38</th>
      <td></td>
      <td>after 3 weeks</td>
      <td>applied atorvastatin in rats after 3 weeks of drinking green tea or water.</td>
    </tr>
    <tr>
      <th>23</th>
      <td></td>
      <td>8-day period</td>
      <td>does not affect CYP2C19 activity when administered over an 8-day period.</td>
    </tr>
    <tr>
      <th>36</th>
      <td></td>
      <td>for thousands of years</td>
      <td>Jiawei Xiaoyao San (JWXYS) is a very common Chinese herbal formula used by the Chinese for thousands of years (Chen et al., 2014).</td>
    </tr>
    <tr>
      <th>35</th>
      <td></td>
      <td>14 days</td>
      <td>The selected volunteers were randomized to placebo (inert substitute for a treatment or intervention) or MenoAct851 formulation (500 mg BID for 14 days in double-blind fashion) groups.</td>
    </tr>
    <tr>
      <th>28</th>
      <td></td>
      <td>for 7 days</td>
      <td>on the 7th day, 2 h after APG 40 mg/kg administration, and Group IV was administered with APG 40 mg/kg for 7 days.</td>
    </tr>
    <tr>
      <th>25</th>
      <td></td>
      <td>15 min</td>
      <td>After administration, aspirin is rapidly hydrolyzed in the body with an elimination half-life of approximatly 15 min [11,12].</td>
    </tr>
    <tr>
      <th>37</th>
      <td></td>
      <td>12 weeks</td>
      <td>Previous studies in human participants have shown promising effects of YM ingestion on metabolic rate and RER acutely [21], and after 12 weeks of ingestion, on blood lipid metabolites in healthy obese participants [11,21].</td>
    </tr>
    <tr>
      <th>31</th>
      <td></td>
      <td>Two weeks</td>
      <td>Two weeks of coadministration of H. sabdariffa extract is sufficient enough to affect the GSH level or the expression of the PEPT1 transporter.</td>
    </tr>
    <tr>
      <th>24</th>
      <td></td>
      <td>for thousands of years</td>
      <td>Herbs have been used for primary health care for thousands of years before the advent of modern medicines.</td>
    </tr>
    <tr>
      <th>26</th>
      <td></td>
      <td>after four days</td>
      <td>Effects of Samento (0.033–1%) and the positive control rifampicin (20 µM) on the protein expression of P-glycoprotein (P-gp) after four days of exposure.</td>
    </tr>
    <tr>
      <th>33</th>
      <td></td>
      <td>15 day</td>
      <td>One brief 15 day study reported a significant increase in total cholesterol among hypertensive patients administered HS [18].</td>
    </tr>
  </tbody>
</table>
<span class="table_title">False Positives</span>

<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th>generated</th>
      <th>gold</th>
      <th>text</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th>1</th>
      <td>1.0 mL</td>
      <td></td>
      <td>The loss of body fluid was compensated by administrating 1.0 mL saline solution (p.o.)</td>
    </tr>
    <tr>
      <th>0</th>
      <td>for the duration of the study</td>
      <td></td>
      <td>In Stage 2 77 additional participants were randomized to either 1,200 mg S. frutescens or placebo.</td>
    </tr>
    <tr>
      <th>2</th>
      <td>in vitro</td>
      <td></td>
      <td>Curcuminoids have been shown to inhibit CY3A4 and 2C9 in vitro [230].</td>
    </tr>
  </tbody>
</table>

</body>
</html>
